A Purdue University-affiliated bioanalytics startup has been awarded a $1.4 million grant from the National Institutes of Health for its work on an instrument used to test antibody purity.
Novilytic LLC has received a Phase II Small Business Innovation Research contract to help with the development and commercialization of the Proteometer.
The company says the instrument is being created for process chemists and engineers who need to develop better process quality and control.
The technology would be used by pharmaceutical antibody manufacturers, which are developing treatments for cancers, diseases and viruses.
“The Proteometer represents a truly disruptive technology that will allow process research and manufacturing chemists and engineers to monitor and control antibody growth in process,” said Fred Regnier, chief technology officer and co-founder of Novilytic. “There is no technology available to do this currently.”
Regnier says the company, which is also launching a seed round funding opportunity, will be opening new laboratories and hiring additional scientists in the coming months in the West Lafayette area.